2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …

G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Geriatric elements and oral anticoagulant prescribing in older atrial fibrillation patients: SAGE‐AF

JS Saczynski, SR Sanghai, CI Kiefe… - Journal of the …, 2020 - Wiley Online Library
OBJECTIVES Oral anticoagulants are the cornerstone of stroke prevention in high‐risk
patients with atrial fibrillation (AF). Geriatric elements, such as cognitive impairment and …

Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based …

S Kumar, S de Lusignan, A McGovern, A Correa… - bmj, 2018 - bmj.com
Objective To assess the association between anticoagulation, ischaemic stroke,
gastrointestinal and cerebral haemorrhage, and all cause mortality in older people with atrial …

[HTML][HTML] Acute heart failure in elderly patients: a review of invasive and non-invasive management

G Tersalvi, A Gasperetti, M Schiavone… - Journal of geriatric …, 2021 - ncbi.nlm.nih.gov
Acute heart failure (AHF) is a major cause of unplanned hospitalisations in the elderly and is
associated with high mortality. Its prevalence has grown in the last years due to population …

Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk

SA Lubitz, S Khurshid, LC Weng, G Doros… - American heart …, 2018 - Elsevier
Background Many patients with atrial fibrillation (AF) and elevated stroke risk are not
prescribed oral anticoagulation (OAC) despite evidence of benefit. Identification of factors …

Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme

M Mazurek, JL Halperin, MV Huisman, HC Diener… - EP …, 2020 - academic.oup.com
Aims To assess antithrombotic therapy choices in relation to patient age in a large, global
registry on atrial fibrillation (AF). Methods and results Global Registry on Long-Term Oral …

Oral anticoagulant use and appropriateness in elderly patients with atrial fibrillation in complex clinical conditions: ACONVENIENCE study

C Bonanad, F Formiga, M Anguita, R Petidier… - Journal of clinical …, 2022 - mdpi.com
Non-valvular atrial fibrillation (NVAF) is the most common arrhythmia in older patients.
Although direct-acting oral anticoagulants (DOAC) are the antithrombotic treatment of …

[HTML][HTML] Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillation

MG Abrignani, A Lombardo, A Braschi… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Since 2010, the European Society of Cardiology has extended prescription
criteria for oral antithrombotic therapy (OAT) in atrial fibrillation (AF). Direct oral …

Wytyczne ESC 2020 dotyczące diagnostyki i leczenia migotania przedsionków opracowane we współpracy z European Association of Cardio‑Thoracic Surgery …

G Hindricks, T Potpara, N Dagres… - Polish Heart …, 2021 - journals.viamedica.pl
Urządzenia implantowane/zewnętrzne urządze‑nia monitorujące umożliwiają wykrycie
AHRE/subklinicznego AF (RYCINA 1). 3 Ze względu na krót‑ki czas monitorowania …

Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience

I Gorczyca, O Jelonek, A Michalska, M Chrapek… - Medicine, 2020 - journals.lww.com
Patients aged≥ 75 years with the diagnosis of atrial fibrillation (AF) are at a higher risk of
stroke and, according to recent recommendations, should receive oral anticoagulant (OAC) …